CXCL14 enhances proliferation and migration of NCI-H460 human lung cancer cells overexpressing the glycoproteins containing heparan sulfate or sialic acid

Journal of Cellular Biochemistry

Volumn 114, Issue 5, 2013, Pages 1084-1096

  Park, Cho Rong ^a   You, Dong Joo ^a   Kim, Dong Kyu ^a   Moon, Mi Jin ^a   Lee, Cheolju ^b   Oh, Seung Hyun ^c   Ahn, Curie ^d   Seong, Jae Young ^a   Hwang, Jong Ik ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Gachon University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

CXCL14; glycoprotein; heparan sulfate proteoglycan; migration; NF B; sialic acid

Indexed keywords

BREFELDIN A; CXCL14 CHEMOKINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOSIALIN; N ACETYLNEURAMINIC ACID; PODOPLANIN; SIALIC ACID; SYNDECAN 4;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CALCIUM SIGNALING; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES, CXC; ENDOCYTOSIS; GLYCOPROTEINS; HEK293 CELLS; HEPARITIN SULFATE; HUMANS; LUNG NEOPLASMS; N-ACETYLNEURAMINIC ACID; NF-KAPPA B; PROTEIN BINDING; RECEPTORS, FC;

EID: 84875146604     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24449     Document Type: Article

References (36)

1. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K,. 2004. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
2. Almaraz RT, Tian Y, Bhattarcharya R, Tan E, Chen SH, Dallas MR, Chen L, Zhang Z, Zhang H, Konstantopoulos K, Yarema KJ,. 2012. Metabolic flux increases glycoprotein sialylation: Implications for cell adhesion and cancer metastasis. Mol Cell Proteomics.
3. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G,. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182: 155-162.
4. Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM,. 1997. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol 62: 554-562.
5. Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T, Frederick MJ, Borg A, Micke P, Egevad L, Ostman A,. 2009. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA 106: 3414-3419.
6. Cao X, Zhang W, Wan T, He L, Chen T, Yuan Z, Ma S, Yu Y, Chen G,. 2000. Molecular cloning and characterization of a novel CXC chemokine macrophage inflammatory protein-2 gamma chemoattractant for human neutrophils and dendritic cells. J Immunol 165: 2588-2595.
7. Frederick MJ, Henderson Y, Xu X, Deavers MT, Sahin AA, Wu H, Lewis DE, El-Naggar AK, Clayman GL,. 2000. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 156: 1937-1950.
8. Fuster MM, Esko JD,. 2005. The sweet and sour of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer 5: 526-542.
9. Jiang D, Liang J, Campanella GS, Guo R, Yu S, Xie T, Liu N, Jung Y, Homer R, Meltzer EB, Li Y, Tager AM, Goetinck PF, Luster AD, Noble PW,. 2010. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 120: 2049-2057.
10. Kim JE, You DJ, Lee C, Ahn C, Seong JY, Hwang JI,. 2010. Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. Cell Signal 22: 1645-1654.
11. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B,. 2001. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med 194: 855-861.
12. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN,. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38: 12959-12968.
13. Lin ZP, Boller YC, Amer SM, Russell RL, Pacelli KA, Patierno SR, Kennedy KA,. 1998. Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: Involvement of NF-kappaB activation in drug resistance. Cancer Res 58: 3059-3065.
14. Lodi PJ, Garrett DS, Kuszewski J, Tsang ML, Weatherbee JA, Leonard WJ, Gronenborn AM, Clore GM,. 1994. High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. Science 263: 1762-1767.
15. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D,. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872.
16. Luster AD, Greenberg SM, Leder P,. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182: 219-231.
17. Maerki C, Meuter S, Liebi M, Muhlemann K, Frederick MJ, Yawalkar N, Moser B, Wolf M,. 2009. Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections. J Immunol 182: 507-514.
18. Misra S, Ghatak S, Zoltan-Jones A, Toole BP,. 2003. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 278: 25285-25288.
19. Mosheimer BA, Kaneider NC, Feistritzer C, Djanani AM, Sturn DH, Patsch JR, Wiedermann CJ,. 2005. Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes. J Clin Endocrinol Metab 90: 2964-2971.
20. Nara N, Nakayama Y, Okamoto S, Tamura H, Kiyono M, Muraoka M, Tanaka K, Taya C, Shitara H, Ishii R, Yonekawa H, Minokoshi Y, Hara T,. 2007. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem 282: 30794-30803.
21. Perkins ND,. 2012. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12: 121-132.
22. Peterson FC, Thorpe JA, Harder AG, Volkman BF, Schwarze SR,. 2006. Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome. J Mol Biol 363: 813-822.
23. Rot A,. 1992. Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol Today 13: 291-294.
24. Rothwarf DM, Karin M,. 1999. The NF-kappa B activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE 1999: R E1.
25. Rybak ME, Gimbrone MA Jr, Davies PF, Handin RI,. 1989. Interaction of platelet factor four with cultured vascular endothelial cells. Blood 73: 1534-1539.
26. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B,. 2005. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23: 331-342.
27. Shellenberger TD, Wang M, Gujrati M, Jayakumar A, Strieter RM, Burdick MD, Ioannides CG, Efferson CL, El-Naggar AK, Roberts D, Clayman GL, Frederick MJ,. 2004. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 64: 8262-8270.
28. Shurin GV, Ferris RL, Tourkova IL, Perez L, Lokshin A, Balkir L, Collins B, Chatta GS, Shurin MR,. 2005. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174: 5490-5498.
29. Sleeman MA, Fraser JK, Murison JG, Kelly SL, Prestidge RL, Palmer DJ, Watson JD, Kumble KD,. 2000. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int Immunol 12: 677-689.
30. Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Nakayama J, Fujimoto I, Ikenaka K, Wada H,. 2000. Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. Cancer Res 60: 3072-3080.
31. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S,. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361: 79-82.
32. Tanegashima K, Okamoto S, Nakayama Y, Taya C, Shitara H, Ishii R, Yonekawa H, Minokoshi Y, Hara T,. 2010. CXCL14 deficiency in mice attenuates obesity and inhibits feeding behavior in a novel environment. PLoS One 5: e10321.
33. Tessema M, Klinge DM, Yingling CM, Do K, Van Neste L, Belinsky SA,. 2010. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene 29: 5159-5170.
34. Turley EA, Noble PW, Bourguignon LY,. 2002. Signaling properties of hyaluronan receptors. J Biol Chem 277: 4589-4592.
35. Uhlin-Hansen L, Yanagishita M,. 1995. Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells. Biochem J 310: 271-278.
36. Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, Giese NA, Buchler MW, Friess H,. 2008. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 259: 209-217.